|
JP2013205362A
|
|
Colorectal cancer marker and prognosis prediction method
|
|
WO2011105573A1
|
|
Anti-icam3 antibody and use thereof
|
|
WO2010074049A1
|
|
Anti-hs6st2 antibody and use thereof
|
|
WO2009004822A1
|
|
ANTI-Muc17 ANTIBODY
|
|
WO2009001840A1
|
|
Anti-prominin-1 antibody having adcc activity or cdc activity
|
|
CN101951953A
|
|
Contain the pharmaceutical composition of anti-GRP78 antibody as effective ingredient
|
|
EP2123754A1
|
|
CHIMERIC Fc GAMMA RECEPTOR AND METHOD FOR DETERMINATION OF ADCC ACTIVITY BY USING THE RECEPTOR
|
|
US2010111852A1
|
|
Anti-Claudin 3 Monoclonal Antibody and Treatment and Diagnosis of Cancer Using the Same
|
|
EP2078731A1
|
|
Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
|
|
WO2008029601A1
|
|
Cancer therapeutic agent comprising ligand for neuromedin u receptor 2 (fm4) molecule as active ingredient
|
|
CN101505791A
|
|
Diagnosis and treatment of cancer using anti-desmoglein-3 antibody
|
|
JP2010215510A
|
|
Therapeutic agent for lymphoma
|
